- Home
- FMBH vs COLL Comparison
FMBH vs COLL Comparison
Compare FMBH & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FMBH
- COLL
- Stock Information
- Founded
- FMBH 1865
- COLL 2002
- Country
- FMBH United States
- COLL United States
- Employees
- FMBH N/A
- COLL N/A
- Industry
- FMBH Major Banks
- COLL Biotechnology: Pharmaceutical Preparations
- Sector
- FMBH Finance
- COLL Health Care
- Exchange
- FMBH Nasdaq
- COLL Nasdaq
- Market Cap
- FMBH 974.1M
- COLL 1.1B
- IPO Year
- FMBH N/A
- COLL 2015
- Fundamental
- Price
- FMBH $35.73
- COLL $36.00
- Analyst Decision
- FMBH Hold
- COLL Strong Buy
- Analyst Count
- FMBH 5
- COLL 4
- Target Price
- FMBH $43.40
- COLL $44.25
- AVG Volume (30 Days)
- FMBH 67.7K
- COLL 325.7K
- Earning Date
- FMBH 10-30-2025
- COLL 11-06-2025
- Dividend Yield
- FMBH 2.80%
- COLL N/A
- EPS Growth
- FMBH 12.54
- COLL N/A
- EPS
- FMBH 3.65
- COLL 1.06
- Revenue
- FMBH $335,099,000.00
- COLL $707,007,000.00
- Revenue This Year
- FMBH N/A
- COLL $21.29
- Revenue Next Year
- FMBH $4.16
- COLL $3.36
- P/E Ratio
- FMBH $9.79
- COLL $34.00
- Revenue Growth
- FMBH 5.91
- COLL 22.61
- 52 Week Low
- FMBH $27.58
- COLL $23.23
- 52 Week High
- FMBH $43.86
- COLL $39.95
- Technical
- Relative Strength Index (RSI)
- FMBH 41.94
- COLL 58.95
- Support Level
- FMBH $36.32
- COLL $33.89
- Resistance Level
- FMBH $37.20
- COLL $35.90
- Average True Range (ATR)
- FMBH 1.12
- COLL 1.02
- MACD
- FMBH 0.01
- COLL 0.27
- Stochastic Oscillator
- FMBH 39.55
- COLL 97.57
About FMBH First Mid Bancshares Inc.
First Mid Bancshares Inc is a United States based financial holding company. Through its wholly-owned subsidiary, First Mid Bank, it is engaged in the business of banking. The Company offers trust, farm services, investment services, and retirement planning through its wholly owned subsidiary, it also provides data processing services to affiliates and insurance products and services to customers through its subsidiary. The company's operations cover community banking, wealth management and insurance services. Key revenue is derived from the provision of community banking services.
About COLL Collegium Pharmaceutical Inc.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.